Orthofix Medical Inc.: ARMISTICE CAPITAL, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Armistice Capital, LLC amended its Schedule 13G stake filing for Orthofix Medical Inc., disclosing the change to the SEC under accession number 0001172661-26-005247. The filing updates the investment firm's previously reported beneficial ownership position in the medical device maker. Schedule 13G amendments are typically filed by investors with passive stakes of 5% or more, making the disclosure a signal of Armistice's current holding size. Investors will watch for further 13G or 13D filings to gauge whether Armistice's position remains passive or shifts toward activism.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Armistice Capital, LLC, Orthofix Medical Inc.